Investors

29 October 2025

Silicon Biochip meets performance and clinical requirements

→

27 October 2025

Quarterly Activities/Appendix 4C Cash Flow Report

→

22 October 2025

Presentation - Semiconductor Australia 2025

→

21 October 2025

Notice of Annual General Meeting/Proxy Form

→

17 October 2025

Archer and Emergence partner to pursue graphene quantum tech

→

15 October 2025

AXE builds on EDMR quantum breakthrough to advance qubit development

→

19 September 2025

Notice Required Under ASX Listing Rule 3.13.1

→

11 September 2025

Investor Presentation - September 2025

→

08 September 2025

Notification regarding unquoted securities - AXE

→

01 September 2025

Archer Strengthens Biochip Commercialisation Path

→

28 August 2025

FY25 Results and Appendix 4E

→

28 August 2025

2025 Corporate Governance Statement and Appendix 4G

→

28 August 2025

2025 Annual Report

→

12 August 2025

AXE to Unlock Scalable Potassium Sensor Production with IMEC

→

28 July 2025

Biosensor advancements support broader platform potential

→

14 July 2025

Quarterly Activities Report & Appendix 4C

→

10 July 2025

TMR Sensor Functionality at Cryogenic Temperature

→

03 July 2025

Archer Advances Quantum Technology

→

02 June 2025

Notification of cessation of securities - AXE

→

02 June 2025

Change of Director's Interest Notice x 3

→